Re: Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes

被引：1
|
作者：
Villers, Arnauld [1 ]
Olivier, Jonathan [1 ]
机构：
[1] Lille Univ, Dept Urol, 2 Ave Oscar Lambret, F-59037 Lille, France
来源：
EUROPEAN UROLOGY | 2018年 / 74卷 / 03期
关键词：
D O I：
10.1016/j.eururo.2018.03.024
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [1] Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes
    Cooperberg, Matthew R.
    Brooks, James D.
    Faino, Anna, V
    Newcomb, Lisa F.
    Kearns, James T.
    Carroll, Peter R.
    Dash, Atreya
    Etzioni, Ruth
    Fabrizio, Michael D.
    Gleave, Martin E.
    Morgan, Todd M.
    Nelson, Peter S.
    Thompson, Ian M.
    Wagner, Andrew A.
    Lin, Daniel W.
    Zheng, Yingye
    [J]. EUROPEAN UROLOGY, 2018, 74 (02) : 211 - 217
  • [2] Is It Time to Revisit the Role of Prostate-specific Antigen Kinetics in Active Surveillance for Prostate Cancer?
    Iremashvili, Viacheslav
    Kava, Bruce R.
    Manoharan, Murugesan
    Parekh, Dipen J.
    Punnen, Sanoj
    [J]. UROLOGY, 2016, 95 : 139 - 144
  • [3] REFINED ANALYSIS OF PROSTATE SPECIFIC ANTIGEN (PSA) VELOCITY TO PREDICT OUTCOMES IN ACTIVE SURVEILLANCE: RESULTS FROM THE CANARY PROSTATE ACTIVE SURVEILLANCE STUDY (PASS)
    Cooperberg, Matthew
    Brooks, James
    Faino, Anna
    Zheng, Yingye
    Kearns, James
    Carroll, Peter
    Dash, Atreya
    Fabrizio, Michael
    Gleave, Martin
    Morgan, Todd
    Nelson, Peter
    Thompson, Ian
    Wagner, Andrew
    Newcomb, Lisa
    Lin, Daniel
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E558 - E558
  • [4] Value of Prostate-Specific Antigen Kinetics in Patients with Low-Risk Prostate Cancer under Active Surveillance
    Fernandez-Anguita, Pedro Jesus
    Ventosa-Puig, Marta
    Diaz-de-Mera-Sanchez-Migallon, Inmaculada
    Legido-Gomez, Oscar
    Carrion-Lopez, Pedro
    Martinez-Ruiz, Jesus
    Salinas-Sanchez, Antonio Santiago
    Gimenez-Bachs, Jose Miguel
    [J]. UROLOGIA INTERNATIONALIS, 2023, 107 (07) : 706 - 712
  • [5] PREDIAGNOSTIC PROSTATE-SPECIFIC ANTIGEN KINETICS ARE NOT ASSOCIATED WITH THE RISK OF PROGRESSION IN PROSTATE CANCER PATIENTS MANAGED WITH ACTIVE SURVEILLANCE
    Iremashvili, Viacheslav
    Barney, Shane
    Manoharan, Murugesan
    Kava, Bruce
    Parekh, Dipen J.
    Punnen, Sanoj
    [J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E231 - E232
  • [6] Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients
    Iremashvili, Viacheslav
    Manoharan, Murugesan
    Lokeshwar, Soum D.
    Rosenberg, Daniel L.
    Pan, David
    Soloway, Mark S.
    [J]. BJU INTERNATIONAL, 2013, 111 (03) : 396 - 403
  • [7] ACTIVE SURVEILLANCE FOR PROSTATE CANCER: RETHINKING PROSTATE-SPECIFIC ANTIGEN DENSITY ELIGIBILITY CRITERIA
    Ha, Yunsok
    Patel, Neal
    Salmasi, Amirali
    Singer, Eric
    Yu, Jihyeong
    Kim, Jeong Hyun
    Kim, Wun-Jae
    Kim, Isaac Yi
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E821 - E821
  • [8] Can prostate-specific antigen nadir predict prostate cancer outcomes following radiotherapy?
    Lee, W. Robert
    Moul, Judd W.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (10): : 534 - 535
  • [9] Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
    Kim, Sang Jin
    Jeong, Tae Yoong
    Yoo, Dae Seon
    Park, Jinsung
    Cho, Seok
    Kang, Seok Ho
    Lee, Sang Hyub
    Jeon, Seung Hyun
    Lee, Tchun Yong
    Park, Sung Yul
    [J]. YONSEI MEDICAL JOURNAL, 2015, 56 (06) : 1492 - 1496
  • [10] Can prostate-specific antigen nadir predict prostate cancer outcomes following radiotherapy?
    W Robert Lee
    Judd W Moul
    [J]. Nature Clinical Practice Oncology, 2006, 3 : 534 - 535
12345